VBI Vaccines, Inc. (VBIV) Financials
VBIV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 100.8 million | 80.9 million |
2023-06-30 | 88.3 million | 79.6 million |
2023-03-31 | 128.5 million | 83.4 million |
2022-12-31 | 155.1 million | 90.9 million |
VBIV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.1 million | 1.5 million |
2023-06-30 | -19.3 million | 1.7 million |
2023-03-31 | -22.2 million | 2.0 million |
2022-12-31 | -20.5 million | 2.3 million |
VBIV Net Income
No data available :(
VBIV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 35.5 million | - | 2.4 million |
2023-06-30 | 20.8 million | 47.8 million | 2.7 million |
2023-03-31 | 40.4 million | - | 3.0 million |
2022-12-31 | 62.6 million | 48.9 million | 3.3 million |
VBIV Shares Outstanding
VBIV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 113000 | 1.5 million | 9.0 million | - |
2023-06-30 | 50000 | 3.3 million | 10.9 million | - |
2023-03-31 | 534000 | 3.2 million | 13.3 million | - |
2022-12-31 | 1.5 million | 2.5 million | 15.9 million | - |
VBIV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 6.6 million | 2.5 million |
2023-06-30 | 720000 | 3.5 million |
2023-03-31 | 485000 | 3.6 million |
2022-12-31 | 293000 | 3.3 million |
VBIV
Price: $0.57
52 week price:
Earnings Per Share: -9.79 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 314214
Ebitda: -32.9 millionMarket Capitalization: 16.8 million
Average Dividend Frequency: 1